Literature DB >> 23160227

Idiopathic intracranial hypertension: a unifying neuroendocrine hypothesis through the adrenal-brain axis.

Vincenzo Salpietro1, Agata Polizzi, Luca Francesco Bertè, Roberto Chimenz, Valeria Chirico, Sara Manti, Valeria Ferraù, Annamaria Salpietro, Teresa Arrigo, Martino Ruggieri.   

Abstract

The clinical syndrome idiopathic intracranial hypertension (IIH), also termed pseudotumor cerebri, consists of symptoms of headache, nausea, vomiting and visual field defects in combination with findings of papilledema. IIH is more commonly seen in overweight women where the rise in intracranial pressure is putatively a consequence of an endocrine-based disturbance of electrolytes. Less frequently, it can also occur in men and in the pediatric age group. Associated risk factors include primary and secondary aldosteronism, pregnancy, recombinant growth hormone (r-GH) therapy, oral contraceptives, obesity, vitamin A intoxication or deficiency, Addison disease, corticosteroid therapy or acute withdrawal of steroid therapy and Cushing disease. Herein, we review the association between these conditions and IIH working toward its having a unifying neuroendocrine hypothesis.

Entities:  

Mesh:

Year:  2012        PMID: 23160227

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  12 in total

1.  [Pseudotumor cerebri syndrome].

Authors:  K Rüther
Journal:  Ophthalmologe       Date:  2014-04       Impact factor: 1.059

2.  Role of vitamin A metabolism in IIH: Results from the idiopathic intracranial hypertension treatment trial.

Authors:  J Libien; M J Kupersmith; W Blaner; M P McDermott; S Gao; Y Liu; J Corbett; M Wall
Journal:  J Neurol Sci       Date:  2016-11-10       Impact factor: 3.181

3.  Neurocutaneous melanocytosis (melanosis).

Authors:  Martino Ruggieri; Agata Polizzi; Stefano Catanzaro; Manuela Lo Bianco; Andrea D Praticò; Concezio Di Rocco
Journal:  Childs Nerv Syst       Date:  2020-10-13       Impact factor: 1.475

Review 4.  Pediatric Pseudotumor Cerebri Syndrome: Diagnosis, Classification, and Underlying Pathophysiology.

Authors:  Claire A Sheldon; Grace L Paley; Shannon J Beres; Shana E McCormack; Grant T Liu
Journal:  Semin Pediatr Neurol       Date:  2017-04-07       Impact factor: 1.636

5.  Introduction to phacomatoses (neurocutaneous disorders) in childhood.

Authors:  Martino Ruggieri; Agata Polizzi; Gioacchino Paolo Marceca; Stefano Catanzaro; Andrea D Praticò; Concezio Di Rocco
Journal:  Childs Nerv Syst       Date:  2020-09-17       Impact factor: 1.475

Review 6.  An integrated mechanism of pediatric pseudotumor cerebri syndrome: evidence of bioenergetic and hormonal regulation of cerebrospinal fluid dynamics.

Authors:  Claire A Sheldon; Young Joon Kwon; Grant T Liu; Shana E McCormack
Journal:  Pediatr Res       Date:  2014-11-24       Impact factor: 3.756

7.  The Bone Mineral Density of the Lateral Skull Base and its Relation to Obesity and Spontaneous Cerebrospinal Fluid Leaks.

Authors:  Jonathan L Hatch; Heather Schopper; Isabel M Boersma; Habib G Rizk; Shaun A Nguyen; Paul R Lambert; Theodore R McRackan; Ted A Meyer
Journal:  Otol Neurotol       Date:  2018-10       Impact factor: 2.311

Review 8.  Adrenal disorders and the paediatric brain: pathophysiological considerations and clinical implications.

Authors:  Vincenzo Salpietro; Agata Polizzi; Gabriella Di Rosa; Anna Claudia Romeo; Valeria Dipasquale; Paolo Morabito; Valeria Chirico; Teresa Arrigo; Martino Ruggieri
Journal:  Int J Endocrinol       Date:  2014-09-03       Impact factor: 3.257

9.  Addison's Disease Presenting With Idiopathic Intracranial Hypertension in a Young Female.

Authors:  Abigail K Fowlie; Muhammad S Majeed; Eleni Karathanasi
Journal:  Cureus       Date:  2021-05-23

Review 10.  Idiopathic intracranial hypertension, hormones, and 11β-hydroxysteroid dehydrogenases.

Authors:  Keira A Markey; Maria Uldall; Hannah Botfield; Liam D Cato; Mohammed A L Miah; Ghaniah Hassan-Smith; Rigmor H Jensen; Ana M Gonzalez; Alexandra J Sinclair
Journal:  J Pain Res       Date:  2016-04-19       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.